Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tuberculosis | 7 | 2019 | 2895 | 0.90 | Why? |
| Brazil | 25 | 2021 | 12582 | 0.88 | Why? |
| Tuberculosis, Pulmonary | 3 | 2019 | 1171 | 0.71 | Why? |
| Public Health Surveillance | 2 | 2020 | 3129 | 0.63 | Why? |
| Latent Tuberculosis | 2 | 2018 | 324 | 0.63 | Why? |
| Population Groups | 1 | 2017 | 212 | 0.59 | Why? |
| Arthralgia | 1 | 2017 | 173 | 0.58 | Why? |
| National Health Programs | 1 | 2020 | 807 | 0.50 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.48 | Why? |
| Cluster Analysis | 2 | 2018 | 3001 | 0.48 | Why? |
| Disease Eradication | 1 | 2018 | 581 | 0.45 | Why? |
| Prisoners | 5 | 2018 | 738 | 0.39 | Why? |
| Dilleniaceae | 2 | 2018 | 2 | 0.37 | Why? |
| Ventilation | 1 | 2015 | 1145 | 0.35 | Why? |
| Oils, Volatile | 2 | 2019 | 127 | 0.33 | Why? |
| Prisons | 2 | 2017 | 980 | 0.32 | Why? |
| State Medicine | 1 | 2020 | 2847 | 0.31 | Why? |
| Suicide | 1 | 2018 | 1500 | 0.28 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.27 | Why? |
| Disease Outbreaks | 4 | 2020 | 27595 | 0.26 | Why? |
| Syphilis | 2 | 2018 | 318 | 0.26 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.25 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.25 | Why? |
| beta-Lactamases | 3 | 2019 | 759 | 0.24 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.24 | Why? |
| Tuberculosis, Multidrug-Resistant | 2 | 2018 | 433 | 0.23 | Why? |
| Plant Extracts | 3 | 2018 | 1514 | 0.23 | Why? |
| Communicable Diseases, Imported | 2 | 2020 | 843 | 0.23 | Why? |
| Klebsiella pneumoniae | 2 | 2019 | 658 | 0.23 | Why? |
| Biomedical Research | 2 | 2018 | 5270 | 0.21 | Why? |
| Origanum | 1 | 2019 | 3 | 0.21 | Why? |
| Tuberculin Test | 2 | 2018 | 141 | 0.20 | Why? |
| Gene Expression Regulation, Bacterial | 2 | 2017 | 143 | 0.20 | Why? |
| DNA, Fungal | 1 | 2019 | 95 | 0.20 | Why? |
| Serratia marcescens | 1 | 2019 | 38 | 0.20 | Why? |
| Fever | 1 | 2017 | 7795 | 0.20 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.19 | Why? |
| Leptospira | 1 | 2019 | 48 | 0.19 | Why? |
| Psidium | 1 | 2017 | 1 | 0.18 | Why? |
| Leptospirosis | 1 | 2019 | 103 | 0.18 | Why? |
| Enterobacter cloacae | 1 | 2017 | 58 | 0.17 | Why? |
| Treponema pallidum | 1 | 2017 | 42 | 0.17 | Why? |
| Global Health | 2 | 2018 | 13911 | 0.17 | Why? |
| Sesquiterpenes | 1 | 2017 | 77 | 0.17 | Why? |
| Indians, South American | 1 | 2018 | 126 | 0.17 | Why? |
| Family Characteristics | 2 | 2018 | 2551 | 0.16 | Why? |
| Gene Expression Regulation, Enzymologic | 2 | 2017 | 436 | 0.16 | Why? |
| Fetal Development | 1 | 2018 | 173 | 0.16 | Why? |
| Cell-Free Nucleic Acids | 1 | 2019 | 271 | 0.16 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.16 | Why? |
| Antitubercular Agents | 3 | 2017 | 775 | 0.16 | Why? |
| Antigens, Bacterial | 1 | 2019 | 330 | 0.15 | Why? |
| Acinetobacter baumannii | 1 | 2019 | 378 | 0.15 | Why? |
| Central Nervous System Diseases | 1 | 2021 | 410 | 0.15 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.15 | Why? |
| Mycobacterium tuberculosis | 3 | 2019 | 1164 | 0.15 | Why? |
| DNA, Bacterial | 1 | 2019 | 835 | 0.15 | Why? |
| Reproduction | 1 | 2018 | 259 | 0.14 | Why? |
| Spleen | 1 | 2019 | 877 | 0.14 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.14 | Why? |
| Adolescent Health | 1 | 2018 | 227 | 0.14 | Why? |
| Gram-Negative Bacteria | 1 | 2019 | 473 | 0.14 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2017 | 260 | 0.14 | Why? |
| Immune Tolerance | 1 | 2019 | 608 | 0.13 | Why? |
| Facility Design and Construction | 1 | 2015 | 189 | 0.13 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.13 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.13 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.12 | Why? |
| Adult | 16 | 2021 | 244371 | 0.12 | Why? |
| Humans | 34 | 2021 | 930598 | 0.12 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.12 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.12 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.11 | Why? |
| Male | 21 | 2021 | 367725 | 0.11 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.11 | Why? |
| Female | 20 | 2021 | 380317 | 0.11 | Why? |
| Enterobacteriaceae Infections | 1 | 2017 | 529 | 0.11 | Why? |
| Educational Status | 1 | 2018 | 1451 | 0.11 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.11 | Why? |
| Klebsiella Infections | 1 | 2016 | 466 | 0.11 | Why? |
| Surgical Wound Infection | 1 | 2016 | 501 | 0.10 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.10 | Why? |
| Sexually Transmitted Diseases | 1 | 2017 | 694 | 0.10 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.10 | Why? |
| Shock, Septic | 1 | 2019 | 1313 | 0.09 | Why? |
| DNA, Viral | 1 | 2019 | 2521 | 0.09 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.09 | Why? |
| Child Health | 1 | 2018 | 940 | 0.09 | Why? |
| Environmental Exposure | 1 | 2019 | 1558 | 0.09 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.09 | Why? |
| Anti-Bacterial Agents | 3 | 2020 | 10083 | 0.09 | Why? |
| Pleurisy | 2 | 2017 | 18 | 0.09 | Why? |
| Seroconversion | 1 | 2018 | 2515 | 0.09 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.08 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.08 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.08 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.08 | Why? |
| Early Diagnosis | 1 | 2015 | 2443 | 0.08 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.08 | Why? |
| Research | 1 | 2019 | 2115 | 0.08 | Why? |
| Public Policy | 1 | 2018 | 1894 | 0.07 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.07 | Why? |
| Cough | 1 | 2019 | 4891 | 0.07 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.07 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.07 | Why? |
| Rural Population | 1 | 2017 | 2408 | 0.07 | Why? |
| Socioeconomic Factors | 2 | 2020 | 8495 | 0.07 | Why? |
| Antibodies, Viral | 1 | 2017 | 51949 | 0.07 | Why? |
| Edema | 2 | 2017 | 333 | 0.07 | Why? |
| Young Adult | 7 | 2019 | 93724 | 0.06 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
| Child | 4 | 2020 | 70012 | 0.06 | Why? |
| Adolescent | 5 | 2019 | 86841 | 0.06 | Why? |
| Aged | 8 | 2021 | 215776 | 0.06 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.06 | Why? |
| Anti-Inflammatory Agents | 2 | 2017 | 6153 | 0.05 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.05 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Infant | 3 | 2020 | 30274 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.05 | Why? |
| Micronuclei, Chromosome-Defective | 1 | 2018 | 8 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.05 | Why? |
| Guinea Pigs | 1 | 2019 | 420 | 0.05 | Why? |
| Dust | 1 | 2019 | 178 | 0.04 | Why? |
| Comet Assay | 1 | 2017 | 6 | 0.04 | Why? |
| Paraguay | 1 | 2017 | 23 | 0.04 | Why? |
| Micronucleus Tests | 1 | 2017 | 12 | 0.04 | Why? |
| Tannins | 1 | 2017 | 44 | 0.04 | Why? |
| Contact Tracing | 1 | 2017 | 8448 | 0.04 | Why? |
| Abnormalities, Drug-Induced | 1 | 2018 | 72 | 0.04 | Why? |
| History, 19th Century | 1 | 2019 | 384 | 0.04 | Why? |
| Hyperalgesia | 1 | 2017 | 61 | 0.04 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.04 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.04 | Why? |
| Solvents | 1 | 2018 | 139 | 0.04 | Why? |
| Bolivia | 1 | 2017 | 187 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 113 | 0.04 | Why? |
| Models, Theoretical | 1 | 2015 | 6659 | 0.04 | Why? |
| Plant Leaves | 1 | 2017 | 233 | 0.04 | Why? |
| Child, Preschool | 2 | 2019 | 36283 | 0.04 | Why? |
| Carbapenems | 1 | 2019 | 343 | 0.04 | Why? |
| Carrageenan | 1 | 2017 | 123 | 0.04 | Why? |
| Fungi | 1 | 2019 | 471 | 0.04 | Why? |
| Oseltamivir | 1 | 2020 | 583 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.04 | Why? |
| Aircraft | 1 | 2020 | 498 | 0.04 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 183 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Blood Specimen Collection | 1 | 2019 | 387 | 0.04 | Why? |
| Body Fluids | 1 | 2019 | 451 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Stakeholder Participation | 1 | 2018 | 481 | 0.04 | Why? |
| Phenols | 1 | 2017 | 226 | 0.04 | Why? |
| Phagocytosis | 1 | 2017 | 409 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.03 | Why? |
| Mice | 3 | 2019 | 21357 | 0.03 | Why? |
| Diffusion of Innovation | 1 | 2018 | 440 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2019 | 1444 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.03 | Why? |
| Public Health | 1 | 2019 | 16359 | 0.03 | Why? |
| History, 20th Century | 1 | 2019 | 1282 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Ethanol | 1 | 2018 | 533 | 0.03 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.03 | Why? |
| Flavonoids | 1 | 2017 | 492 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2017 | 1517 | 0.03 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.03 | Why? |
| Animals | 5 | 2019 | 78931 | 0.03 | Why? |
| Plants, Medicinal | 1 | 2018 | 622 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.03 | Why? |
| Sputum | 1 | 2019 | 1720 | 0.03 | Why? |
| Phytotherapy | 1 | 2018 | 743 | 0.03 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 533 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Cooperative Behavior | 1 | 2018 | 1216 | 0.03 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Infectious Disease Incubation Period | 1 | 2017 | 1033 | 0.02 | Why? |
| Cross-Sectional Studies | 4 | 2017 | 53120 | 0.02 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Bacteria | 1 | 2019 | 1897 | 0.02 | Why? |
| Antioxidants | 1 | 2017 | 1593 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2016 | 1414 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Viruses | 1 | 2019 | 2238 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Aerosols | 1 | 2019 | 5393 | 0.02 | Why? |
| Information Dissemination | 1 | 2018 | 2986 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Specimen Handling | 1 | 2019 | 6190 | 0.01 | Why? |
| Travel | 1 | 2020 | 7220 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2019 | 48226 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
Croda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(171)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_